Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Clinical trial NCT01184989 · COMPLETED

Trial details

NCT number: NCT01184989
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Arthroplasty, Replacement Prevention of Venous Thromboembolism Moderate Renal Impairment (CrCl 30-50 mL/Min)

Start date: 2010-08-01
Primary completion: 2013-04-01
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.